Sarah Hrebien

London, ENG SW36JB, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing.

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing.

Journal: Science advances

Published: July 10, 2026

ctDNA monitoring using tumor-informed copy number analysis.

ctDNA monitoring using tumor-informed copy number analysis.

Journal: EMBO molecular medicine

Published: August 05, 2025

Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer.

Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer.

Journal: Breast cancer research and treatment

Published: July 09, 2024

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 04, 2024

Association of post-operative ctDNA detection with outcomes of patients with early breast cancers.

Association of post-operative ctDNA detection with outcomes of patients with early breast cancers.

Journal: ESMO open

Published: January 17, 2024

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA.

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA.

Journal: Nature communications

Published: July 17, 2021

Genomic profile of advanced breast cancer in circulating tumour DNA.

Genomic profile of advanced breast cancer in circulating tumour DNA.

Journal: Nature communications

Published: June 29, 2020

Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers.

Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers.

Journal: Cancer discovery

Published: April 30, 2020

Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer.

Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer.

Journal: Journal of the National Cancer Institute

Published: January 13, 2020

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.

Journal: JAMA oncology

Published: August 02, 2019

Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis.

Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis.

Journal: Clinical chemistry

Published: April 02, 2019

Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial.

Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 13, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026